About VETIGENICS LLC
Vetigenics is a pet biotech company pioneering precision medicine for pets with cancer and other chronic diseases through innovative targeted antibody-based therapies, including monoclonal antibodies for dogs and cats. The company was founded in 2017 through an NCI SBIR award and utilizes a proprietary phage display platform to produce canine antibodies.
Development of monoclonal antibodies for dogs and catsProduction of CANIBODIES™ using a phage display platformConducting clinical trials for dogs with cancerAdvancing comparative oncology researchScreening high-quality antibodies against target antigens without immunizations or animal sacrifice
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| MOONSHOT - TOPIC 372 - DEVELOPMENT AND VALIDATION OF NON-MOUSE REAGENTS TO ENABLE PRECLINICAL DEVELOPMENT OF N | Department of Health and Human Services | $2.0M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to VETIGENICS LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.